Overview

Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DM

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate how EFB0027 and EFB0026 behave in subjects with type 2 diabetes mellitus. In addition, this study will compare the effects of EFB0027 and EFB0026 on circulating concentrations of glucose and gastrointestinal hormones in subjects with type 2 diabetes mellitus.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Elcelyx Therapeutics, Inc.
Treatments:
Hormones
Metformin